21 companies

Gilead Sciences

Market Cap: AR$172.3b

A biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally.

GILD

AR$56,600.00

7D

5.4%

1Y

47.7%

Amgen

Market Cap: US$226.7b

Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide.

AMGND

US$14.40

7D

1.1%

1Y

54.3%

Bristol-Myers Squibb

Market Cap: AR$132.0b

Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, distributes, and sells biopharmaceutical products worldwide.

BMY

AR$34,720.00

7D

3.3%

1Y

65.9%

Bristol-Myers Squibb

Market Cap: US$132.0b

Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, distributes, and sells biopharmaceutical products worldwide.

BMYD

US$23.00

7D

0.7%

1Y

50.8%

Bayer

Market Cap: AR$47.9b

Operates as a life science company in Europe, the Middle East, Africa, Germany, Switzerland, North America, the United States, the Asia Pacific, China, Latin America, and Brazil.

BAYN

AR$31,100.00

7D

n/a

1Y

n/a

Novo Nordisk

Market Cap: US$1.3t

Engages in the research and development, manufacture, and distribution of pharmaceutical products.

NVOD

US$6.86

7D

-3.2%

1Y

n/a

GSK

Market Cap: US$74.2b

Engages in the research, development, and manufacture of vaccines, specialty medicines, and general medicines to prevent and treat disease in the United Kingdom, the United States, and internationally.

GSKD

US$12.87

7D

-4.6%

1Y

30.9%

Novo Nordisk

Market Cap: AR$1.3t

Engages in the research and development, manufacture, and distribution of pharmaceutical products.

NVO

AR$10,230.00

7D

-4.1%

1Y

n/a

GSK

Market Cap: AR$74.2b

Engages in the research, development, and manufacture of vaccines, specialty medicines, and general medicines to prevent and treat disease in the United Kingdom, the United States, and internationally.

GSK

AR$19,540.00

7D

-3.1%

1Y

51.8%

Gilead Sciences

Market Cap: US$172.3b

A biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally.

GILDD

US$37.26

7D

7.8%

1Y

24.2%

Biogen

Market Cap: AR$30.9b

Biogen Inc. discovers, develops, manufactures, and delivers therapies in the United States, Europe, Germany, Asia, and internationally.

New

BIIB

AR$25,360.00

7D

2.3%

1Y

83.1%

AstraZeneca

Market Cap: AR$183.1b

A biopharmaceutical company, focuses on the discovery, development, manufacture, and commercialization of prescription medicines.

AZN

AR$63,225.00

7D

0.5%

1Y

22.4%

Tempus AI

Market Cap: AR$9.3b

Operates as a healthcare technology company in the United States.

TEM

AR$6,500.00

7D

-11.4%

1Y

-18.3%

Biogen

Market Cap: US$30.9b

Biogen Inc. discovers, develops, manufactures, and delivers therapies in the United States, Europe, Germany, Asia, and internationally.

New

BIIBD

US$16.99

7D

1.0%

1Y

72.3%

Amgen

Market Cap: AR$226.7b

Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide.

AMGN

AR$22,410.00

7D

2.8%

1Y

74.4%

Vertex Pharmaceuticals

Market Cap: AR$130.7b

Operates as a biotechnology company in the United States, Europe, and internationally.

New

VRTX

AR$8,270.00

7D

-0.06%

1Y

64.7%

Novartis

Market Cap: US$234.5b

Researches, develops, manufactures, distributes, markets, and sells pharmaceutical medicines in Switzerland and internationally.

NVSD

US$39.45

7D

-1.4%

1Y

34.6%

Novartis

Market Cap: AR$238.7b

Researches, develops, manufactures, distributes, markets, and sells pharmaceutical medicines in Switzerland and internationally.

NVS

AR$61,075.00

7D

-0.3%

1Y

49.8%

Vertex Pharmaceuticals

Market Cap: US$130.7b

Operates as a biotechnology company in the United States, Europe, and internationally.

New

VRTXD

US$5.40

7D

-2.0%

1Y

40.4%

Tempus AI

Market Cap: US$9.3b

Operates as a healthcare technology company in the United States.

TEMD

US$4.51

7D

-5.3%

1Y

-25.3%

AstraZeneca

Market Cap: US$183.1b

A biopharmaceutical company, focuses on the discovery, development, manufacture, and commercialization of prescription medicines.

AZND

US$41.54

7D

0.8%

1Y

4.6%